×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RVPH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
05:31 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/19
08:47 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
11/12
08:00 am
rvph
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025
Low
Report
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025
11/10
08:18 am
rvph
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis [Yahoo! Finance]
Medium
Report
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis [Yahoo! Finance]
11/10
08:00 am
rvph
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis
Medium
Report
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis
10/29
08:00 am
rvph
Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference
Low
Report
Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference
10/28
02:23 pm
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
Low
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
10/28
08:00 am
rvph
Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025
Medium
Report
Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2025
04:05 pm
rvph
reviva pharmaceuticals holdings, inc.
BEAT
Report
-10.5%
reviva pharmaceuticals holdings, inc.
8/14/2025
04:25 pm
rvph
reviva pharmaceuticals holdings, inc.
BEAT
Report
17.0%
reviva pharmaceuticals holdings, inc.
5/15/2025
04:05 pm
rvph
reviva pharmaceuticals holdings, inc.
BEAT
Report
-3.5%
reviva pharmaceuticals holdings, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/4
04:21 pm
rvph
Form ARS REVIVA PHARMACEUTICALS For: Dec 31
Low
Report
Form ARS REVIVA PHARMACEUTICALS For: Dec 31
11/4
04:21 pm
rvph
Form DEFA14A REVIVA PHARMACEUTICALS
Low
Report
Form DEFA14A REVIVA PHARMACEUTICALS
11/4
04:17 pm
rvph
Form DEF 14A REVIVA PHARMACEUTICALS For: Dec 18
Low
Report
Form DEF 14A REVIVA PHARMACEUTICALS For: Dec 18
10/24
04:31 pm
rvph
Form PRE 14A REVIVA PHARMACEUTICALS For: Dec 18
High
Report
Form PRE 14A REVIVA PHARMACEUTICALS For: Dec 18
10/17
04:32 pm
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Oct 14
Medium
Report
Form 8-K REVIVA PHARMACEUTICALS For: Oct 14
9/29
06:59 pm
rvph
Form SCHEDULE 13G REVIVA PHARMACEUTICALS Filed by: 683 Capital Management, LLC
High
Report
Form SCHEDULE 13G REVIVA PHARMACEUTICALS Filed by: 683 Capital Management, LLC
9/26
05:10 pm
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Sep 26
Medium
Report
Form 8-K REVIVA PHARMACEUTICALS For: Sep 26
9/24
04:34 pm
rvph
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: Bhat Laxminarayan
Low
Report
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: Bhat Laxminarayan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: